Rv1324 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

26 results for “Rv1324”

Trials

View all 11 →

A Study of V132 in Healthy Older Participants (V132-001)

280 participants · First posted Jul 17, 2026

Study of Olutasidenib and Temozolomide in HGG

60 participants · First posted Dec 8, 2023

PEP-1324: Glycemic Response Testing

12 participants · First posted Jan 16, 2014

Drugs

View all 11 →

RH324

F1324

BMS-751324

News

Breakthrough Tuberculosis Drug Targets and Novel Therapeutic Strategies Show Promise Against Drug-Resistant Strains

Positive First-in-Human Data for NIM-1324 in Systemic Lupus Erythematosus Treatment Announced

NImmune Biopharma Presents Positive First-in-Human Data of NIM-1324 at ACR Convergence 2023

Page 1 of 3